Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an increasing
number of publications have dealt with multiple aspects of SMZL diagnosis, molecular …

Several studies suggest that immune‐mediated pathways are important in the pathogenesis
of chronic lymphocytic leukaemia (CLL). The in vivo accumulation of leukaemic …

In chronic lymphocytic leukemia (CLL), TP53 gene defects, due to deletion of the 17p13
locus and/or mutation(s) within the TP53 gene, are associated with resistance to …

Chronic lymphocytic leukaemia (CLL) is a frequent disease in which the genetic alterations
determining the clinicobiological behaviour are not fully understood. Here we describe a …

The chronic lymphocytic leukemia (CLL) immunoglobulin repertoire is biased and
characterized by the existence of subsets of cases with closely homologous (“stereotyped”) …

… Anagnostopoulos, HM-B., NL, GJ, SP, and JJ provided samples and associated clinicopathologic
data and supervised research; and K. Stamatopoulos designed the study, supervised …

Multiple distinct memory B-cell subsets have been identified in humans, but it remains
unclear how their phenotypic diversity corresponds to the type of responses from which they …

Richter syndrome (RS) represents the development of diffuse large B-cell lymphoma in the
context of chronic lymphocytic leukemia. The scarcity of biologic information about RS has …

Through the European Research Initiative on chronic lymphocytic leukemia (CLL)(ERIC),
we screened 3490 patients with CLL for mutations within the NOTCH1 (n= 3334), SF3B1 (n= …

Somatic hypermutation (SHM) features in a series of 1967 immunoglobulin heavy chain
gene (IGH) rearrangements obtained from patients with chronic lymphocytic leukemia (CLL) …